Decrease in tumor volume and histologic response to intraarterial neoadjuvant chemotherapy in patients with cervical and endometrial adenocarcinoma

Gynecologic Oncology

Volumn 65, Issue 2, 1997, Pages 258-264

  Fujiwaki, Ritsuto ^a   Takahashi, Kentaro ^a   Kitao, Manabu ^a  

^a SHIMANE UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; CISPLATIN; CYCLINE; DOXORUBICIN;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER REGRESSION; CANCER STAGING; CLINICAL ARTICLE; DNA DETERMINATION; ENDOMETRIUM CARCINOMA; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; TREATMENT OUTCOME; UTERINE CERVIX CARCINOMA; UTERUS BIOPSY;

EID: 0031149771     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1997.4638     Document Type: Article

References (28)

1. Kavanagh J J, Gershenson D, Copeland L, Roberts W AS. Combination chemotherapy for metastatic or recurrent adenocarcinoma of the cervix. J Clin Oncol. 5:1987;1621-1624.
2. Thigpen J T, Blessing J A, Fowler W C. Phase II trials of cisplatin and piperazinedione as single agents in the treatment of advanced or recurrent non-squamous cell carcinoma of the cervix: A Gynecologic Oncology Group Study. Cancer Treat Res. 70:1987;1097-1110.
3. Pasmantier M W, Coleman M, Silver R T, Mamaril A P, Quiguyan C C, Galindo A. Treatment of advanced endometrial carcinoma with doxorubicin and cisplatin: effect on both untreated and previously treated patients. Cancer Treat Res. 69:1985;539-542.
4. Burke T W, Stringer C A, Morris M, Freedman R S, Gershenson D M, Kavanagh J J, Edwards C L. Prospective treatment of advanced or recurrent endometrial carcinoma with cisplatin, doxorubicin, and cyclophosphamide. Gynecol Oncol. 40:1991;264-267.
5. Kohno Y, Iwanari O, Kitao M. Prognostic importance of histologic vascular density in cervical cancer treated with hypertensive intraarterial chemotherapy. Cancer. 72:1993;2394-2400.
6. Hata K, Hata T, Manabe A, Kitao M. Transvaginal doppler ultrasound assessment of intratumoral hemodynamic change before and during hypertensive intra-arterial chemotherapy for uterine cancer. Obstet Gynecol. 80:1992;801-804.
7. Hata K, Hata T, Fujiwaki R, Manabe A, Kitao M. Hypertensive intra-arterial chemotherapy for endometrial carcinoma assessed by transvaginal doppler ultrasound and magnetic resonance imaging. J Clin Ultrasound. 23:1995;407-411.
8. Remvikos Y, Beuzeboc A, Voillent N, Magdelenat H, Pouillart P. Correlation of pretreatment proliferative activity of breast cancer with the response to cytotoxic chemotherapy. J Natl Cancer Inst. 81:1989;1383-1387.
9. Schmidt R A, Conrad E U, Collins C, Rabinovitch P, Finney A. Measurement and prediction of the short-term response of soft tissue sarcoma to chemotherapy. Cancer. 72:1993;2593-2601.
10. Scotlandi K, Serra M, Manara C, Maurici D, Benini S, Nini G, Campanacci M, Baldini N. Clinical relevance of Ki-67 expression in bone tumors. Cancer. 75:1995;806-811.
11. Hartmann L C, Sebo T J, Kamel N A, Podratz K C, Cha S S, Wieand H S, Keeny G L, Roche P C. Proliferating cell nuclear antigen in epithelial ovarian cancer: Relation to results at second-look laparotomy and survival. Gynecol Oncol. 47:1992;191-195.
12. Hickey K, Grehan D, Reid I M, Briain S O, Walsh T N, Hennessy T PJ. Expression of epidermoid growth factor receptor and proliferating cell nuclear antigen predicts response of esophageal squamous cell carcinoma to chemotherapy. Cancer. 74:1994;1693-1698.
13. Thomas H, Nasim M M, Sarrsf C H, Alison M R, Love S, Lambert H E, Price P. Proliferating cell nuclear antigen (PCNA) immunostaining - A prognostic factor in ovarian cancer. Br J Cancer. 71:1995;357-362.
14. Spyratos F, Brifford M, Hulin M, Andrieu C, Mayras C, Pallud C, Mayras C, Filleul A, Rousse J. Sequential cytopunctures during preoperative chemotherapy for primary breast carcinoma. Cancer. 69:1992;470-475.
15. Kigawa J, Kanamori Y, Ishihara H, Minagawa Y, Iwamoto K, Terakawa N. Response rate and cell-cycle changes due to intra-arterial infusion chemotherapy with cisplatin and bleomycin for locally recurrent uterine cervical cancer. Am J Clin Oncol. 15:1992;474-479.
16. Masters J RW, Camplejohn R S, Millis R R, Rubens R D. Histological grade, elastosis, DNA ploidy and the response to chemotherapy of breast cancer. Br J Cancer. 55:1987;455-457.
17. Duhaylongsod F G, Gottfrid M R, Iglehart J D, Vaughn A L, Wolfe W G. The significance of c-erb B-2 and p53 immunoreactivity in patients with adenocarcinoma of the esophagus. Ann Surg. 211:1994;677-684.
18. Sarkis A S, Bajorin D F, Reuter V E, Herr H W, Netto H G, Zhang Z F, Schultz P K, Cordon-Cardo C, Scher H I. Prognostic value of p53 nuclear overexpression in patients with invasive bladder cancer treated with neoadjuvant MVAC. J Clin Oncol. 13:1995;1984-1990.
19. Inoue M, Okayama A, Fujita M, Enomoto T, Sakata M, Tanizawa O, Ueshima H. Clinicopathological characteristics of p53 overexpression in endometrial cancers. Int J Cancer. 58:1994;14-19.
20. Greene D R, Taylor S R, Wheeler T M, Scardino P T. DNA ploidy by image analysis of individual foci of prostate cancer: A preliminary report. Cancer Res. 51:1991;4048-4049.
21. Kim K H, Lee B H, Do Y S, Chin S Y, Park S Y, Kim B G, Jang J J. Stage IIb cervical carcinoma: MR evaluation of effect of intraarterial chemotherapy. Radiology. 192:1994;61-65.
22. Park S Y, Kim B G, Kim J H, Lee J H, Lee E D, Lee K H, Park K B, Kim K H. Phase I/II study of neoadjuvant intraarterial chemotherapy with mitomycin-C, vincristine, and cisplatin in patients with stage IIb bulky cervical carcinoma. Cancer. 76:1995;814-823.
23. Scarabelli C, Zarrelli A, Gallo A, Visentin M C. Multimodal treatment with neoadjuvant intraarterial chemotherapy and radical surgery in patients with stage IIIB-VIA cervical cancer. Cancer. 76:1995;1019-1026.
24. Patton T J, Kavanagh J J, Delclos L, Wallace S, Haynie T P, Gershenson D M, Wharton J T, Bass S. Five-year survival in patients given intra-arterial chemotherapy prior to radiotherapy for advanced squamous carcinoma of the cervix and vagina. Gynecol Oncol. 42:1991;54-59.
25. Sironi S, Belloni C, Taccagni G, Delmaschio A. Invasive cervical carcinoma: MR imaging after preoperative chemotherapy. Radiology. 180:1991;719-722.
26. Hall P A, Levison D A, Woods A L, Kellock D B, Watkins J A, Barnes D M, Gillett C E, Camplejohn R, Dover R, Waseem N H, Lane D P. Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: An index of cell proliferation with evidence of deregulated expression in some neoplasms. J Pathol. 162:1990;285-294.
27. Lowe S W, Ruley H E, Jacks T, Housman D E. p53-dependent apotosis modulates the cytotoxicity of anticancer agents. Cell. 74:1993;957-967.
28. Devita V T. The relationship between tumor mass and resistance to chemotherapy. Cancer. 51:1983;1209-1220.